Tag: CVIR

Eluvia DES

Real-world registry shows sustained efficacy for Eluvia DES in the SFA

This advertorial is sponsored by Boston Scientific.  During a satellite symposium session dedicated to real cases and trial outcomes which was held at the Cardiovascular...
wrapsody first study

“Very encouraging” 12-month data from WRAPSODY FIRST study presented at CIRSE...

Twelve-month results from a first-in-human study of the Wrapsody cell-impermeable endoprosthesis (Merit Medical Systems) for the treatment of access circuit stenosis in haemodialysis patients...